Ethnopharmacological relevance: Lycium is widely distributed in the arid to semi-arid environments of North and South America, Africa, and Eurasia. In recent years, Lycium barbarum and L. chinense have been advertised as "superfood" with healthy properties. Despite of its popularity, there is a lack of an integrated and critical appraisal of the existing evidence for the use of Lycium. Aim of the study: There is a need to understand: 1) Which species were used and how the uses of Lycium developed spatially and over time, 2) how uses differ among regions with different culture backgrounds, and 3) how traditional and current therapeutic and preventive health claims correlate with pharmacological findings. Methods: Information was retrieved from floras, taxonomic, botanical, and ethnobotanical databases, research articles, recent editions of historical Chinese herbals over the last 2000 years, and pharmacopoeias. Results: Of totally 97 species, 31 have recorded uses as food and/or medicine worldwide. Usually the fruits are used. While 85 % of the Lycium species occur in the Americas and Africa, 26 % of them are used, but 9 out of 14 species in Eurasia. In China, seven species and two varieties of the genus Lycium occur, of which four species have been used by different ethnic groups. Only L. barbarum and L. chinense have been transformed into globally traded commodities. In China, based on the name "枸杞", their use can be traced back over the last two millennia. Lycium fruits for anti-aging, improving eyesight and nourishment were documented already in 500 C.E. (Mingyi Bielu). Recent findings explain the pharmacological foundations of the traditional uses. Especially polysaccharides, zeaxanthin dipalmitate, vitamins, betaine, and mixed extracts were reported to be responsible for anti-aging, improving eyesight, and antifatigue effects.
Introduction
Plant-based products are important sources of both food and medicine. Whether a plant is used as food or medicine depends on a wide range of factors, but is not necessarily intrinsic to its pharmacological or nutritional properties (Leonti, 2011; Jennings, et al., 2015) . In the last decades the variety of consumed crops has increased globally, especially of local agricultural varieties and species collected from the wild. These are becoming more important for human nutrition and for medicinal uses (Heywood, 2011) . This increase is often based on traditional knowledge, which is defined as knowledge innovations and practices of indigenous and local communities embodying traditional lifestyles relevant for the conservation and sustainable use of biological diversity (Xue, 2011) . Traditional knowledge on plants can be used as a starting point to develop new medicines, e.g., the discovery of artemisinin (Tu, 2015) , while it should be protected subject to the Nagoya Protocol (Ngo, et al., 2013; Buch and Hamilton, 2011) . Therefore, traditional knowledge on plants continues to play an important role in human lives for both food and medical purposes.
The fruit, leaf, root bark, and young shoot of many species of the genus Lycium L. have long been used as local foods and/or medicines. Recently, Lycium fruits, known as goji or wolfberry, have become increasingly popular in the western world because of their nutritional properties (Qian, et al., 2017; Amagase, 2010; Potterat, 2010; Amagase and Farnsworth, 2011) ; they are even advertised as "superfood" in Europe and North America (Wolfe, 2010; Chang and So, 2015) . Phytochemical studies indicate that the richness in numerous constitutions of different classes, such as polysaccharides, carotenoids, flavonoids, alkaloids, amides, terpenoids, and so on, endows Lycium species with a variety of biological activities (Qian, et al., 2017; Yao et al., 2011) . Also, pharmacopoeias adopted the most popular species, L. barbarum and/or L. chinense, as herbal medicines (Wagner, et al., 2011) .
Thus, species of the genus Lycium serve as widely used source of food and medicine. Despite of its popularity, there is a lack of an integrated and critical appraisal of the existing evidence for the use of Lycium. From a botanical and ethnopharmacological perspective, there is a need to understand: 1) Which species were used and how the uses of Lycium developed spatially and over time, 2) how uses differ among regions with different culture backgrounds, and 3) how traditional and current therapeutic and preventive health claims correlate with pharmacological findings.
To answer these questions we started with a botanical overview of the genus and its accepted species, and did a comprehensive study and analysis of a large body of literature and databases. Pharmacopoeia (1953 ) British Pharmacopoeia (2017 .
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For species names and synonyms we relied on The Plant List (2013) and local floras. Distribution data and biogeographic information were obtained from IPNI (2015) , GBIF (2017 ), LycieaeWeb (2017 and research articles. Morphological characters were extracted from the regional floras and type specimens in the Chinese National Herbarium (PE) were consulted for verification.
To gather information about the use of Lycium species at a global level, the following strategy was used: 1) "Lycium" was used as key word to search within the ethnobotanical databases (table 1) . 2) In google scholar, "Lycium" and "traditional" or "ethnobotany" or "medicine" or "food" or "herb" were searched.
3) The validated species names were searched within the ethnobotanical databases and google scholar. And 4) the words "ethnobotanical suvery" were searched, then "Lycium" was searched in the texts. 5) "Lycium" was also searched in regional ethnobotanical and herbal medicine monographs. Results were integrated with species data.
For the history of Lycium's use we focused on China, both because a continuous documentation over the last two millennia is available, and the current boom of goji use originated in China. We relied on modern translations of classical Chinese herbals. At least one herbal per dynasty was included. If several contemporary herbals existed, the most comprehensive one and herbals adding new information were used. In total, 32 herbals from ca. C.E. 100 to 2006 were considered.
In order to find scientific evidence for traditional uses, we did a literature search on the phytochemistry and pharmacology of Lycium species. The main bioactivities and the related compounds or extracts were listed in one table.
To compare Lycium records in pharmacopoeias of different regions, "Lycium" was searched in the pharmacopoeias listed in the Index of the World Pharmacopoeias and Pharmacopoeial Authorities (document QAS/11.453/ Rev.6) published by WHO in 2016. Lycium was only found in the pharmacopoeias of seven Asian countries and regions.
In order to study the change of the records over time, all editions (from 1953 to 2015) of the Chinese pharmacopoeia were consulted.
Additionally, all the parameters for Lycium fruit and Lycium root included in the pharmacopoeias were extracted and analyzed with a cluster analysis to understand the relationships among pharmacopoeias. R and the package "ape" was employed (R Core Team, 2017; Paradis, et al., 2004) for cluster analysis.
Results

Botany
The genus Lycium (Solanaceae) widely grows in arid to semi-arid environments of the temperate zones (Fukuda, et al., 2001; Miller, et al., 2011; GBIF, 2017) . It was first published by Linnaeus, and three species (viz. L. europaeum, L. barbarum, and L. afrum) were described in Species Plantarum (Linnaeus, 1753) . In 1932, Hitchcock published a systematic taxonomic study on 43 Lycium species from the western hemisphere based on morphology (Hitchcock, 1932) . Recently, molecular markers of different genome parts were used to elaborate the phylogenetic relationship within the genus as well as biogeographic events: Lycium originated from the Americas, and then dispersed to Africa and Eurasia; the diversity centers are the Americas and Africa (Olmstead, et al., 1999; Fukuda, et al., 2001; Miller, 2002; Yin, et al., 2005; Levin and Miller, 2005; Levin, et al., 2009a; Levin, et al., 2009b; Iwu, 2014; Dhar, et al., 2011; Van Damme, 1998 ; MPNS,2017
China, Iran
Fruit as food Fruit as medicine Ali, 1980; Azadi, 2007; Li, et al., 2001 ;
L. decumbens Welw. Tabaraki, et al., 2013; Ghasemi, et al., 2013 Toledo, et al., 2010; Trillo, et al., 2014 .
L. europaeum L. Spain, France, Israel, Palestinian Territory, Algeria, Portugal, India, Tunisia, Egypt Fruit and young shoot as food Fruit, leaf, bark, and whole plant are used for a variety of treatments PFAF, 2016; Fratkin, 1996; Dafni & Yaniv, 1994; Said et al., 2002; El Hamrouni, 2001; Boullard, 2001; Pieroni, et al., 2002; AlQuran, 2007; El-Mokasabi, 2014; Turker, 2012; Leporatti, et al., 2009; Licata et al., 2016; MPNS,2017 Abouri, et al., 2012; Ouhaddou, et al,. 2014; Boulila et al., 2015; Abdennacer et al., 2015;  MPNS,2017
Mauritius, Madagascar, South Africa, , 2003; FEIS, 2016; PFAF, 2016; Kindscher, et al., 2012; Saunders, 1920; McClendon, 1921; Powell, 1988; Vines, 1960; Hodgson, 2001; Middleditch, 2012; MPNS,2017; Quattrocchi, 2012 Seifu, 2004; Soltan, et al., 2009; Cherouana et al., 2013; Ghazanfar, 1994; Hassan-Abdallah, et al., 2013 ; Trabsa et al., 2015; Chermat et al., 2015; Sher et al., 2011; Gaweesh et al., 2015; Iwu, 2014; MPNS,2017; El-Ghazali, et al., 2010; Molla, 2011; Dahech et al., 2013 , 2003; FEIS, 2016; Kearney, et al., 1960; Powell, 1988; Vines, 1960; Hodgson, 2001; MPNS,2017; Quattrocchi, 2012 L. truncatum Y.C.
L. tweedianum Griseb According to our findings, at present ninety seven species and six varieties are recognized (Tab 2). Among them, 32 are native to South America, 24 to North America, 24 to Africa, and 12 to Eurasia; two occur in Eurasia as well as Africa. Lycium australe is the only species endemic to Australia, and L. sandwicense is native to the Pacific islands. L. carolinianum occurs in North America as well as the Pacific islands.
Lycium species are shrubs or small trees, often with thorns on the stem and simple, entire leaves. Usually they are differentiated through the thorn on the stem, the shape and size of leaves, the corolla length, the length of stamen, colour of the fruit, the taste of the fruits, and the size and number of seeds. Morphological characters of the typical frequently used species of different continents are summarized in Tab 3. However, the commercial Lycium products are always without these characteristic traits as they are only few parts of the plant, e.g., fruit, root bark and leaf, therefore, morphological techniques solely were not sufficient for the authentication of Lycium products. For example, fruits of L. barbarum and L. chinense, the two most commonly used goji, are difficult to distinguish by eye (Xin, et al., 2013) , which is a challenge for quality assessment in trading. 
L. berlandieri Dunal
Red, globose to ovoid, glabrous.
Solitary or in pairs, pedicels 3-20 mm long; calyx cupshaped, 1-2 mm long, (3)4-or 5-1obed, the lobes usually shorter than the tube, glabrous except for a tuft of hair at the tip of each lobe; corolla blue, pale lavender, or ochroleucous, campanulate-funnelform, 6-7 mm long, the limb 4-or 5-1obed.
Erect shrub to 2.5 m tall, armed with needlelike spines on the younger shoots or nearly unarmed; branches somewhat crooked, glabrous. Leaves 1-3 in a fascicle, linear to elliptic-spatulate, glabrous, apex rounded to acute, margins entire, base attenuate to a short petiole or subsessile.
L. pallidum Miers
Red (drying blackish or purplish), glaucous, subglobose to ovoid, glabrous. Seeds yellowish, widely ovate to subreniform, minutely pitted.
Solitary or occasionally in pairs, pedicel 8-18 mm long; calyx campanulate, 5-9 mm long, 5-1obed, the lobes about equaling or slightly longer than the tube, glabrous; corolla greenish-white, sometimes tinged with purple, funnelform, 15-20 mm long, the limb 5-1obed.
Upright-spreading, much-branched shrubs to 20 dm tall, branches lightly pubescent to glabrous, sparingly armed with stout spines. Leaves mostly fascicled, except on young growth; blade oblanceolate or spatulate, 1-4 cm long, (3)5-15 mm wide, glabrous, apex acute to obtuse, margins entire, base attenuate; petiole 5-10 mm long.
Orange-red, 4 mm broad. Seeds ca. 1.5 mm broad, reniform, brown.
Solitary or paired, white or purple-suffused. Pedicel 3-4 mm long, pilose. Calyx narrow tubular, pilose; lobes 0.5-1 mm long, acute, pubescent. Corolla tube 10-12 mm long; lobes 2.0 mm long, acute, minutely pubescent. Filaments glabrous at the base, subexserted.
A spiny branched shrub 100-180 cm tall, shoots white-tomentose. Spines tomentose towards the base. Leaves 4-25 (-30) x 2.5-6 mm, ellipticoblong to narrow oblong, cuneate, obtuse or acute, pilose to tomentose.
(Flora of China Editorial Committee, 1994; Tutin, 1972; McGregor, et al., 1986; Ali, 1980) 3.2 Traditional uses
Traditional uses worldwide
Of all 97 species, 35species and 2 varieties were found to be used as food and/or medicine (Tab 2). The number of native species of the different continents used as food and medicine are shown in Fig. 1 . Fig. 1 Lycium species used as food and/or medicine on the different continents Although the richness of Lycium species differs in South America, North America, Africa and Eurasia, the numbers of species used are similar. Therefore, the species use ratios are dramatically different. In Eurasia, nine (64 %) of the 14 species, and one variety, are used. While 86 % of the Lycium species occur in the Americas and Africa, only 31 % (26 species) of them are used as food and/or medicine. The Australian species as well as the two Pacific Island species are all used as food.
Of 28 species the plant parts used are the fruits, both for food and medicine, indicating that the fruit is worldwide the most commonly used plant part; of the other species also the leaves and root bark are used, and in some cases the whole plant. Leaves and root bark are usually used as medicine, while young shoots may also be prepared as food. Lycium barbarum, L. chinense, and L. ruthenicum are the most often reported species in the literature for China, L. europeaum, L. intricatum, and L. shawii for the Mediterranean and Middle East, L. pallidum for North America, and L. afrum for Africa. Usually the fresh or dried fruits are consumed, and the fresh leaves are cooked as food or used as tea. Of them, L. barbarum and L. chinense have been introduced as "superfood" from China to Europe, the Americas, and Australia. They are typically consumed as food supplement.
Use of Lycium in China over time
Today, the dried fruits and the root bark of L. chinense and L. barbarum, called Gouqi Zi and Digu Pi, are commonly used in Chinese medicine and diet (Wagner, et al., 2011; Chang & So, 2015; Tan, et al., 2017) . Whether the same or different species have been used in the past is not easy to deduce from the historical herbals, as the species concept did not exist in earlier times; and in the older herbals, even the plant parts used were not recorded. Therefore, information has to be inferred from the Chinese characters and the plant figures in the historical herbals.
The Chinese characters "枸杞" (gǒu qǐ) means Lycium, although sometimes the word means the fruit of Lycium only. However, in the ancient literature the character "杞" alone was often referring to Lycium. "杞" was also present in the oracle bone script, a script which was used in Shang Dynasty (B.C.E. 1400s to B.C.E. 1100s), indicating that the use of Lycium has a long history in China. It also appeared in later scripts, like bronze inscription and seal script. The earliest record of using Lycium in China was found in the Book of Songs (诗经，shī jīng), which consisted of poems written in the Zhou Dynasty (B.C.E. 1100s to B.C.E. 300s) (Gao, 1980) . In the 74 poems of the chapter Xiaoya (小雅，xiǎo yǎ), "杞" was mentioned six times. The sentences, "南山 有杞 (nán shān yǒu qǐ)" and "言采其杞 (yán cǎi qí qǐ)", describe people harvesting Lycium plants growing in the mountains.
Records of Lycium in the Chinese herbals over time are listed in S1, while Fig. 2 shows Lycium illustrations. The earliest record of Lycium as medicine was in Shennong's Herbal (ca. C.E. 100) (Shang, 2008) . The original herbal does not exist anymore, and the present edition was compiled from later citations. The text mentions the flavour, effects, common names, and habitat of Lycium briefly, but not the plant parts used (Li, 1954) . Deduced from the given flavour, it might be the root; from the effects, it could be both fruits and roots; from the recorded common name "枸杞", it might be both fruits and roots, as some later herbals also used the same name for root and/or fruit.
In the Jin Dynasty (C.E. 266 -420), Ge Hong (284 -364) published two herbals, Baopuzi (Ge, 1995) and Zhouhou Beiji Fang (Ge, 1999) , both of which included Lycium. The later was the first herbal with formulas, and Lycium fruit, root, and juice were recorded separately in different formulas. Leigong Paozhi Lun (ca. 420 -479) (Lei, 1985) , the first monograph on processing of materia medica, recorded the manufacture of the root bark, while the fruit decoction was used for processing another drug. Mingyi Bielu (Tao, 1986) , published around C.E. 500, is commonly regarded as the first herbal describing the use of Lycium fruits; however, according to our research, Lycium fruits and root had already been used separately in earlier times (Jin Dynasty by Ge Hong).
Lycium was first recorded as food in Bencaojing Jizhu (ca. C.E. 500) (Tao, 1994) . In Xinxiu Bencao (659) (Su, 1981) and Shiliao Bencao (ca. 700) (Meng, 1984) , Lycium was also recorded as food, with several medicated diet recipes of the fruits, root, and leaves. Later, in Qianjin Yifang (682) (Sun, 1998) , cultivation techniques of Lycium were described, beside its medicinal usages.
New in the Song Dynasty (960 -1279) was the detailed morphological description of the plant accompanied by illustrations. Bencao Tujing (Su, 1994) and Zhenglei Bencao (Tang, 1982) were the most important herbals during Song, and Lycium was recorded in both.
In the Yuan Dynasty (1271 -1368), the recipes of tea, porridge, and wine using the fruit or the leaves were recorded in the medicated diet monograph Yinshan Zhengyao (Hu, 2009) .
Bencao Gangmu (1596) (Li, 1954) , also known as Compendium of Materia Medica, discussed the habitat, the use history, manufacturing, and usage of Lycium, offering a review of former information as well as Li Shizhen's (1518 Shizhen's ( -1593 understanding of its use. In the Ming and Qing Dynasty (1644 -1912), many formulas containing Lycium emerged and were described in various herbals. In 1935, the herbal Zhongguo Yaoxue Da Cidian (Chen, 1935) , for the first time published the scientific name Berberis lycium for 枸杞. This was later found to be a misidentification, and was replaced by Lycium. Besides the key herbals described above, there were still many interesting ones published in different times (Chen, 1988; Chen, 1985; Chen, 2008; Du, 1975; Jiang, 1911; Kou, 1990; Liu, 1956; Lu, 1986; Ni, 2005; Wang, 1987; Wu,1987; Wu, 1959; Yan, 1958; Yang, 1958; Zhu, 2008) ; as a result, these herbals conserved the food and medicine use history of Lycium in China.
The contemporary herbals, such as Zhonghua Bencao (Zhonghua Bencao Editorial Broad, 1999), Xinbian Zhongyao Zhi (Xiao, 2002) Four species have been used in Tibetan medicine, while both L. barbarum and L. chinense by the Uighurs and either of them by the other ethnic groups. Fruits as well as root bark and leaves have been commonly used. The whole plant has been used by the Miao and Yi for different purposes: Miao use it as a tonic, while Yi use it for sores and itching. The Miao's usages are similar to the ancient Chinese herbals' records.
In general, Lycium spp. have often been used for the treatments of blurry vision, fever, night sweat, kidney deficiency, cough and asthma, diabetes, heart diseases, gynecopathy, and neurasthenia. However, the Yi and Dong use them differently, i.e. the fruits of L. chinense are for bleeding gums, while the whole plant as antipruritic drug. They were also used as medicinal food by the Miao and Yi.
Comparison of traditional uses with recent pharmacological studies
Different Lycium species, foremost L. barbarum and L. chinense, were phytochemically analyzed and hundreds of compounds were isolated and identified (Qian, et al., 2017) . Bioactivities and pharmacological effects of crude extracts or compounds were assessed in pharmacological studies and it turns out that many of the traditional uses are supported by these studies. For example, the anti-aging effect of Lycium (probably the whole plant of L. chinense or L. barbarum) has been recorded since Shennong's Herbal (ca. C.E. 100); recent studies demonstrated that polysaccharides, vitamins, pigments, and crude extracts of Lycium fruits are benefitting age-related lesions (Bucheli, et al., 2011; Kim et al., 1997; Tao, et al., 2008; Yi, et al., 2013) . Use for improving eyesight was mentioned in herbals as well, and Zeaxanthin, lutein, and polysaccharides were found to have retinal protection activities (Tang, et al., 2011; Mi, et al., 2012b; Song, et al., 2012; Chu, et al., 2013; Pavan, et al., 2014) . Xiaoke is a term used in ancient herbals, describing symptoms similar to present diabetes (Li, et al., 2004) ; Studies on root bark and fruits of L. chinense and L. barbarum found that water extract, polysaccharides, organic acids, and alkaloids have an effect on lipid metabolism and oxidative restoring of diabetic animals (Ye, et al., 2008; Li, 2007; Luo, et al., 2004) . Also, an anti-fatigue and hepatoprotective effect of Lycium fruits and root bark has been shown recently (Alharbi, et al., 2017; Xiao, et al., 2012; He, et al., 2012; Cui, et al., 2012) , and has been recorded in herbals too.
Tab 5 General bioactivities of compounds or extracts of Lycium spp. Le, et al., 2007; Li & Zhou, 2007; Bai, et al., 2008; Donno, et al., 2015; Benchennouf, 2017; Chung, et al., 2014 ; Wang et al., 2010 Spermatogenesis Polysaccharides (fruit of L. barbarum) Luo, et al., 2014; Qian & Yu, 2016; Shi, et al., 2017 Retinal protection Zeaxanthin and/or lutein, Tang, et al., 2011; Mi, et al., 2012b; Song, et al., 2012; Chu, Alharbi, et al., 2017; Xiao, et al., 2012; Xiao, et al., 2014a; Xiao, et al., 2014b; Zhang, et al., 2010; Ahn, et, al., 2014; Ha, et al., 2005 Anti-aging Fruit, polysaccharides, vitamins, pigments Bucheli, et al., 2011; Kim et al., 1997; Tao, et al., 2008; Yi, et al., 2013 Immunomodulation Polysaccharides-protein complex, polysaccharides, pigments Zhang, et al., 2014; Tang, 2012; Chen, et al., 2012; Chen, et al., 2008; Chen, et al., 2009a; Chen, et al., 2009b; Gan, et al., 2004 Anti-tumor Polysaccharides-protein complex, polysaccharides, mix extract, scopoletin and AA-2βG He, et al., 2012; Cui, et al., 2012; Tang, 2012; Hu, et al., 1994; Gan, et al., 2004; Liu, et al., 2000 Skin care Polysaccharides, juice, glycoconjugate Reeve, et al., 2012; Liang & Zhang, 2007; Zhao, et al., 2005 Anti-microbial Lyciumoside I, AcOEt-soluble fraction Terauchi, et al., 1998; Lee, et al., 2005; Dong-Hyun, 2000 Anti-diabetic Water extract, polysaccharides, organic acids, and alkaloids Ye, et al., 2008; Song, et al., 2012; Li, et al., 2004; Li, 2007; Luo, et al., 2004 ; Jia et al., 2003 Anti-atherosclerosis Seed oil, polysaccharides Jiang, et al., 2007; Ma et al., 2009 Hypotensive Water extract, polysaccharides Kim et al., 1997; Mi, et al., 2012a; Mi, et al., 2012b Neuroprotective Water extract, polysaccharides, alkaline extract Ho, et al., 2007; Chan, et al., 2007; Ho, et al., 2010; Mi, et al., 2013; Wang, et al., 2014 Anti-fatigue Polysaccharides, betaine Wu & Guo, 2015; Kim & Baek, 2014 Since L. barbarum and L. chinense are widely used species, most phytochemical and pharmacological studies have been focusing on the fruits and root bark of these two species. As a result, there are scientific evidences for their medical use, which in turn have been increasing again their popularity. Therefore, they have been adopted in pharmacopoeias of many countries and regions. For example, in the current Chinese pharmacopoeia (2015), there are 75 prescriptions containing fruits of L. barbarum. They were also allowed to be used as cosmetic materials in China. In contrast, only a few studies focused on other Lycium species, which are less widely used.
Lycium in current pharmacopoeias
3.3.1 Lycium in recent pharmacopoeias of the world As sources of common herbal medicines, Lycium species have been incorporated into several pharmacopoeias, including China, Europe, Japan, Korea, Taiwan, UK, and Vietnam (Tab 6). Lycium has not been included in the pharmacopoeia of USA, Russia, Africa, Australia, Brazil, Argentina, Switzerland, Iran, and India. The fruit and/or root bark of L. barbarum and/or L. chinense are the most frequently used materials mentioned in the pharmacopoeias, although the aerial part of L. barbarum and L. europeaum are recorded by the Indian Ayurveda pharmacopoeia. The European pharmacopoeia only includes the dried fruit of L. barbarum.
Lycium fruits (Lycii Fructus) and Lycium root bark (Lycii Radices Cortex) are used in several regions officially, however, the quality criteria differ. Firstly, the species used as Lycii Fructus differ. Lycium chinense is accepted by the pharmacopoeias of Japan, Korea, and Taiwan, but not included in the pharmacopoeias of China, Europe, UK, and Vietnam; while they are not morphologically distinguishable, practically, both of them are consumed widely. Secondly, the descriptions are different. Indications are only included in pharmacopoeias of China, Taiwan, and Vietnam; macroscopic and microscopic traits are included to different degrees. Thirdly, the identification techniques differ. Colour test as primary identification tool, which could be used for detecting some chemical groups, is only used by the Korean pharmacopoeia; TLC, which is much more specificity based on chemical fingerprint and sufficient for species differentiation, is used widely. However, it was not included in the Korean pharmacopoeia until 2012. Lastly, the quality examination indexes and their thresholds differ as well. While betaine, a bioactive compound in Lycii Fructus, is used as index in the pharmacopoeia of China and Korea only, contents of polysaccharides are exclusively mentioned in the Chinese one.
Lycium in Chinese pharmacopoeias
Since 1949, there have been 10 editions of the Chinese pharmacopoeia (Chinese Pharmacopoeia Commission, 1953 , 1963 , 1977 , 1990 , 1995 , 2005 . Lycium species described in the different editions are shown in Table 7 .
Tab 7 Lycium records in Pharmacopoeias of China Lycium was not included in the first edition of the Chinese pharmacopoeia which was published in 1953. While in 1963 L. barbarum and L. chinense were mentioned for their fruits and L. chinense for its root bark. This changes afterwards and L. barbarum was documented for its fruits while both, L. chinense and L. barbarum were used for their root barks.
The descriptions of Lycii Fructus and Lycii Radices Cortex of all editions were similar, but macroscopic traits became more and more detailed over time. Identification and examination indexes, however, changed greatly. In the 1963 edition, the identification was based on macroscopic traits only, later, microscopic, total ash, TLC, loss on drying, impurities, contents of extracts, acid-insoluble ash, and heavy metals were included in succession. The development of pharmacopoeial monographs indicates the progress of quality control of herbal medicines.
Besides the pharmacopoeia, there are still some regional medicinal criteria which are published by provinces of China. Since the environments and the customs may differ among provinces, the records are diverse. For example, in Ningxia, the pedicel of the fruit and leaves of L. barbarum are officially used; in Xinjiang, the fruit of L. dasystemum has been accepted; in Gansu, the root bark of L. truncatum has been an official source of Lycii Radices Cortex (Li, 2001) .
Accordingly, in China the quality criteria of Lycii Fructus and Lycii Radices Cortex have experienced notable developments over time, and they vary by geographic regions.
Comparison of Lycium records among pharmacopoeias
As demonstrated above, the fruits and/or root bark were adopted by pharmacopoeias of many countries and regions, as well as Chinese pharmacopoeias of different times; however, the descriptions and quality requirements were different. In order to understand the relationship of these pharmacopoeias, we extracted the parameters which were used for the identification of Lycium. The Indian Ayurveda pharmacopoeia was not included as it describes the aerial parts of the plant as a medicine, and the Chinese pharmacopoeia 1953 was excluded since it does not record Lycium. The results are shown in Fig. 3 . Accordingly, the clustering is a practical tool to study the development of pharmacopoeia over time, as well as to reveal the relationship among pharmacopoeias of different regions.
Discussion
According to our study, 35 out of 97 Lycium species worldwide have been recorded to be used as food and / or medicine. The species use ratio in the Americas is rather low, maybe because there are many species available there. Alternatively, it would be worth to investigate the abundance of different species in the relevant regions in order to better understand the potential access to these resources. The thorny Lycium species are generally ignored. In order to make better use of less-used Lycium species, phytochemical and pharmacological studies are needed.
Only L. barbarum and L. chinense have been transformed into globally traded commodities and are marketed worldwide as a "super food". In China, based on the Chinese name "枸杞" their use can be traced back over the last two millennia. However, identification of the plant species and plant parts used is often not possible with certainty. Nevertheless, the use of Lycium fruits for anti-aging, improving eyesight and nourishing can be traced back at least C.E. 500 in Mingyi Bielu, and these usages still continue until today in Chinese medicine.
The diversity of plant usages offers opportunities for the development of new food and or medicine products. However, challenges for the quality control will have to be overcome. According to our study, different parts of Lycium species are used, and both of the botanical resources and traditional knowledge are primary materials for developing traditional herbal products (Jütte, et al., 2017; Tu, 2015; Ngo, et al., 2013) . On the other hand, those differences set obstacles with regards to the quality control of the products, and the quality criteria differ greatly among regions. Along with the popularity of the fruits of L. barbarum and L. chinense, they become global consumables. However, almost all the goji are produced in China, and the exporters have to adjust their products to meet the diverse quality requirements of different regions; the different quality criteria among regions will probably obstruct the international trading. Therefore, a relative uniform quality criterion is recommended.
In general, recent pharmacological findings on L. barbarum and L. chinense largely support traditional uses as described in ancient herbals. Especially polysaccharides, zeaxanthin dipalmitate, vitamins, betaine, and mixed extracts were reported to be responsible for anti-aging, improving eyesight, anti-fatigue effects. It is obvious that detailed pharmacognostical studies lay a solid foundation for the wide acceptance of the plants and their products. Therefore, researches also need to focus on those less well-studied species but with interesting biological activities (Yao, et al., 2011; Qian, et al., 2017) as potential new sources of (healthy) foods or medicines. Due to the complexity of herbal preparations, quality control using only few chemical indicators is insufficient. Instead, the metabolomic approaches need to be developed (Donno, et al., 2016) .
Historical documentary evidences are good basis for ethnobotanical study (Heinrich, et al., 2006; Heinrich, et al., 2012; Jütte, et al., 2017) . The historical continuity of Chinese medical herbals showcase the evolution of peoples' medical knowledge and offer ideas for treatment options for current diseases. In this study, the use history of Lycium in China was mapped out using the herbals, and some of the reported effects involved, such as anti-aging, retinal protection, and anti-fatigue, have been demonstrated experimentally. However, there are gaps between the descriptions in Chinese herbals and modern concepts: 1) the species are often not properly described as most of them were not written by botanists but doctors; 2) the terms of diseases and the description of symptoms are difficult to understand because of the difference of medical concepts; 3) the herbals contain historical "clinical data" and both the right and inaccurate information are included. As a result, the herbals are important sources of medicinal and nutritional researches, but they need to be used dialectically.
Conclusions
A comprehensive understanding of a species' characteristics, which includes taxonomy, geographic distribution, traditional use, phytochemistry, pharmacology, knowledge evolution, and quality control, is indispensable for finding new sources for food and/or medicine. This article highlights the need for a very sound understanding of the multi-contextual basis of what is commonly termed a species 'traditional use'. The research approach used had to be transdisciplinary and the integration of historical, modern ethnobotanical, botanical, phytochemical and pharmacological data has enabled a much more detailed understanding of the genus as a whole and its wider potential. It also highlights that the focus so far has only been on two species and that the genus can potentially yield a wide range of other products with different properties.
This research has relied heavily on historical documentary evidences and such sources are good starting points for ethnopharmacological studies. In the present work, a set of time-continuous historical herbals of Chinese medicine generated a database on its usage and has allowed us to better understand the evolution of knowledge about Lycium. Hopefully, this ethnobotanical review incorporating both space and time dimensions will serve as a model for studying traditional food or medicine plants.
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